Skip to main content
ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
109.33
-3.37 (-2.99%)
At close: Mar 6, 2026, 4:00 PM EST
110.49
+1.16 (1.06%)
After-hours: Mar 6, 2026, 7:59 PM EST

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.

Revenue (ttm)
5.31M EUR
Revenue Growth
-42.89%
P/S Ratio
1,361.71
Revenue / Employee
79,269 EUR
Employees
67
Market Cap
8.49B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.79M6.22M135.94%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-300.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Bio-Techne 1.22B
Arrowhead Pharmaceuticals 1.09B
Madrigal Pharmaceuticals 958.40M
Axsome Therapeutics 638.50M
Krystal Biotech 389.13M
ImmunityBio 113.29M
Cytokinetics 88.04M
Revenue Rankings

ABVX News

More News